Lutetium-177 (Lu-177) Market is Segmented by Type (Non-carrier-added, Carrier-added), by Application (Nuclear Therapy, Others). The Lutetium-177 market is poised for significant expansion as demand ...

Discover comprehensive details about Lutetium Lu 177 Dotatate, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

The appraisal committee considered evidence from a number of sources. See the committee papers for full details of the evidence. The committee understood that neuroendocrine tumours (NETs) can affect ...

Review the side-effects of Lutetium Lu 177 Dotatate as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...

IN connexion with the half-life standardization of lutetium-176 (half-life = 2.2 × 2 10 yr.) a 1-g quantity of commercially available lutetium oxide was obtained having a purity of 99.9 per cent.

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

ONTARIO, Canada & MUNICH, Germany--(BUSINESS WIRE)--ITM Medical Isotopes GmbH and Isogen signed a formal supply arrangement to provide a reliable supply of Lutetium-177 to the world’s health care ...

TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline DNA repair gene mutations. This is an ASCO Meeting Abstract from the ...

GARCHING / MUNICH, Germany and INDIANAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and POINT Biopharma Global Inc.